Hypoglycaemia problems and diabetes - Aetiology, diagnosis, and treatment;Hypoglykämieprobleme bei diabetes mellitus - Ätiologie, diagnostik und behandlung

Diabetes und Stoffwechsel

Volumn 13, Issue 3, 2004, Pages 139-151

  Kulzer, Bernhard ^a,b   Hermanns, N ^a   Kubiak, T ^a   Haak, T ^a  

^a Forsch Inst der Diabetes Akademie   (Germany)

^b Diabetes Zentrum Mergentheim   (Germany)

Author keywords

Diabetes; Hypoglycaemia; Hypoglycaemia awareness; Self management

Indexed keywords

INSULIN;

BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; QUESTIONNAIRE; REVIEW; SELF CARE;

EID: 3042624557     PISSN: 09420037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 329 (1993) 977-986
2. UKPDS Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patient with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. DAFNE Study Group: Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. British Medical Journal 325 (2002) 746-749
4. Bragd J, Adamson U, Lins PE, Wredling R, Oskarsson P: A repeated cross-sectional survey of severe hypoglycaemia in 178 type 1 diabetes mellitus patients performed in 1984 and 1998. Diabetic Medicine 20 (2003) 216-219
5. Bott S, Bott U, Berger M, Mühlhauser I: Intensified insulin therapy and the risk of severe hypoglycemia. Diabetologia 40 (1997) 926-932
6. Schiel R, Müller UA: Die Stoffwechselqualität von insulinbehandelten Patienten mit Diabetes mellitus einer mitteldeutschen Stadt 1989/90 bis 1999/2000. Die JEVIN Studie. Medizinische Klinik 98 (2003) 303-312
7. Henderson JN, Allen KV, Deary IJ, Frier BM: Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabetic Medicine 20 (2003) 1016-1021
8. Cryer P: Hypoglycemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45 (2002) 937-948
9. Thefeld W: Prävalenz des Diabetes mellitus in der erwachsenen Bevölkerung Deutschlands. Gesundheitswesen 61 Sonderheft 2 (1999) S85-S89
10. Fisher BM, Heller SR: Mortality, cardiovascular morbidity and possible effects of hypoglycaemia on diabetic complications. In: B. M. Frier, B. M. Fisher (eds.): Hypoglycaemia in clinical diabetes. Wiley, New York (1999) 167-186
11. Kulzer B: Angst vor Unterzuckerungen: das "Hypoglykämie- Angstinventar". In: B. Kulzer, C. W. Kohlmann (eds.): Diabetes und Psychologie. Diagnostische Ansätze. Huber, Bern (1995) 64-82
12. Hermanns N, Kubiak T, Kulzer B, Haak T: Emotional changes during experimentally induced hypoglycaemia in type 1 diabetes. Biological Psychology 63 (2003) 15-44
13. Hermanns N: Selbstregulation als Modell einer modernen Verhaltensmedizin. Eine verhaltensmedizinische Analyse von Hypoglykämieproblemen. Pabst Science Verlag, Lengerich (2003)
14. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T.: Affective and anxiety disorders and their comorbidity in a German sample of diabetic patients: prevalence and risk factors. Diabetic Medicine. In press
15. Polonsky WH, Davis CL, Jacobson AM, Anderson BJ: Correlates of hypoglycemic fear in type I and type II diabetes mellitus. Health Psychology 11 (1992) 199-202
16. Dreyer M, Berger M, Kiess W, Lüdecke HJ, Redaelli M, Schatz H, Waldhäusl W: Therapie des Typ 1 Diabetes. Diabetes und Stoffwechsel 12, Supplement 2 (2003) 49-66
17. Mühlhauser I: Hypoglykämie. In: M. Berger (ed.): Diabetes Mellitus. Urban & Fischer, München (2000) 370-386
18. Cryer PE: Hypoglycemia. Pathophysiology, Diagnosis, and Treatment. Oxford Press, Oxford (1997)
19. Tattersall RB: Frequences, causes and treatment of hypoglycaemia. In: B. M. Frier, B. M. Fisher (eds.): Hypoglycaemia in clinical diabetes. Wiley & Sons, New York (1999) 55-87
20. Cryer P, Davis ND, Shamoon H: Hypoglycemia in Diabetes. Diabetes Care 26 (2003) 1902-1912
21. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV: Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 24 (2001) 1858-1862
22. The Diabetes Control and Complication Trial Research Group: Hypoglycemia in the diabetes control and complication trial. Diabetes 46 (1997) 271-286
23. 1c, und schwere Hypoglykämien nach intensivierter Behandlung und Schulung von Patienten mit Typ 1 Diabetes als klinischer Routine: Ergebnisse eines landesweiten Qualitätszirkels (ASD) 1992-1999. Diabetes und Stoffwechsel 9 (2000) 67-81
24. Hermanns N, Kulzer B, Maier B, Kubiak T, Haak T: Risikoindikatoren für das Auftreten schwerer Hypoglykämien bei Patienten mit Typ-1-Diabetes mellitus, Diabetes und Stoffwechsel 11 (2002) 145-149
25. Pramming S, Thorsteinsson B, Bendtson I, Binder C: Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabetic Medicine 8 (1991) 217-222
26. Henderson JN, Allen KV, Deary IJ, Frier BM: Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness. Diabetic Medicine 20 (2003) 1016-1021
27. Fanelli CG, Pampanelli S, Porcellati F, Bolli GA: Shift of glycemic thresholds for cognitive function in hypoglycaemia unawareness. Diabetologia 41 (1998) 720-723
28. Mitrakou A, Ryan C, Veneman T, Mokan M, Jensen T, Kiss I, Durrant J, Cryer P, Gerich J: Hierarchy of glycemic tresholds for counterregulatory hortmone secretion, symptoms and cerebral dysfunction. Journal of Physiology 260 (1991) E67-E74
29. Amiel SA: Cognitive function testing in studies of acute hypoglycaemia: rights and wrongs? Diabetologia 41 (1998) 713-719
30. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia associated autonomic failure in insulin-dependent diabetes. Journal of Clinical Investigation 91 (1993) 819-828
31. Fruehwald-Schultes B, Peters A, Born J, Fehm H-L, Kern W: Adaptation of cognitive function to hypoglycemia in healthy men. Diabetes Care 23 (2000) 1059-1066
32. Segel SA, Paramore DS, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51 (2002) 724-733
33. Ebert M, Hermanns N, Kubiak T, Kulzer B, Haak T: Einfluss von Einstellungen bezüglich diabetesbedingter Komplikationen auf das Hypoglykämierisiko. Diabetes und Stoffwechsel 10, Supplement 1 (2001) 119
34. Gonder-Frederick L, Cox D, Kovatchev B, Schlundt D, Clarke W: A biopsychobehavioral model of risk of severe hypoglycemia. Diabetes Care 20 (1997) 661-669
35. Cox DJ, Gonder-Frederick LA, Kovatchev B, Young-Hyman D, Schlundt D, Julian DM, Clarke WL: Bio-psycho-behavioral model II. Understanding causes of severe hypoglycemia. Diabetes Care 22 (1999) 2018-2025
36. Clarke WL, Cox DJ, Gonder-Frederick L, Julian D: Reduced awareness of hypoglycemia in adults with IDDM. Diabetes Care 18 (1995) 517-522
37. Schandry R, Leopold C, Vogt M.: Symptom reporting in asthma patients and insulin-dependent diabetics. Biological Psychology 42 (1996) 231-244
38. Kubiak T, Hermanns N: Assessment of hypoglycaemia awareness in type 1 diabetes mellitus. In: J. Fahrenberg, M. Myrtek (eds.): Progress in ambulatory assessment. Hogrefe & Huber, Seattle (2001)
39. Heine RJ: Methods of investigation of insulin induced hypoglycemia. In: B. F. Frier, B. M. Fisher (eds.): Hypoglycemia and diabetes. Edward Arnold, London (1993) 165-175
40. Croxson S: Diabetes in the elderly: problems of care and service provision. Diabetic Medicine 19 (2002) 66-72
41. Swift PGF: Hypoglycaemia in children with diabetes. In: B. M. Frier, B. M. Fisher (eds.): Hypoglycaemia in clinical diabetes. Wiley, New York (1999) 211-242
42. Heller S, Chapman J, McCloud J, Ward J: Unreliability of reports of hypoglycemia by diabetic patients. BMJ 310 (1995) 440
43. Amiel SA: The risks of hypoglycemia with insulin therapy. In: B. Frier, B. M. Fisher (eds.): Hypoglycaemia and diabetes. Clinical and physiological aspects. Edward Arnold, London (1993) 302-313
44. Frier BM, Fisher BM: Impaired hypoglycaemia awareness. In: B. M. Frier, B. M. Fisher (eds.): Hypoglycaemia in clinical diabetes. Wiley & Sons, New York (1999) 111-146
45. Frier BM: Living with hypoglycaemia. In: B. M. Frier, B. M. Fisher (eds.): Hypoglycaemia in clinical diabetes. John Wiley & Sons, New York (1999) 261-290
46. Sommerfield AJ, Ewing FME, Strachan MWJ, Deary IJ, Aitken G, Frier BM: Self-treatment of mild symptomatic hypoglycaemia by people with insulin-treated diabetes. Diabetic Medicine 20 (2003) 686-687
47. Deary IJ: Effects of hypoglycemia on cognitive function. In: B. M. Frier, B. M. Fisher (eds.): Hypoglycemia and diabetes. Edward Arnold, London (1993) 80-92
48. McAulay V, Deary IJ, Frier BM: Symptoms of hypoglycaemia in people with diabetes. Diabetic Medicine 18 (2001) 690-705
49. Ross LA, McCrimmon RJ, Frier BM, Kelnar CJH, Deary IJ: Hypoglycaemic symptoms reported by children with type 1 diabetes mellitus and by their parents. Diabetic Medicine 15 (1998) 843
50. Jaap AJ, Jones CG, McCrimmon RJ, Deary IJ, Frier BM: Perceives symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin. Diabetic Medicine 15 (1998) 398-401
51. Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J: Fear of hypoglycemia: Quantification, validation, and utilization. Diabetes Care 10 (1987) 617-621
52. Polonsky WH, Jacobson A, Anderson BJ, Aponte JE, Lohrer PA, Schwartz CE, Welch G: Assessment of diabetes-related-distress. Diabetes Care 18 (1995) 754-760
53. Welch GW, Jacobson AM, Polonsky WH: The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care 20 (1997) 760-766
54. Kulzer B, Hermanns N, Ebert M, Kempe J, Kubiak T, Haak T: Problembereiche bei Diabetes (PAID) - Ein neues Messinstrument zur Erfassung der emotionalen Anpassung an Diabetes. Diabetes und Stoffwechsel 11, Suppl. 1 (2002) 144
55. Bradley C, Lewis KS: Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabetic Medicine 7 (1990) 445-451
56. Bradley C: Diabetes Treatment Satisfaction Questionnaire (DTQS). In: C. Bradley (ed.): Handbook of Psychology and Diabetes. Harwood Academic Publishers, Amsterdam (1994) 111-132
57. Witthaus E, Stewart J, Bradley C: Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with type 1 diabetes. Diabetic Medicine 18 (2001) 619-625
58. Taylor R, Davies R, Fox C, Sampson M, Weaver JU, Wood L: Appropriate insulin regimes for type 2 diabetes. A multicenter randomized crossover study. Diabetes Care (2000) 1612-1618
59. Kinmonth AL, Woodcock A, Griffin S, Spiegal N, Campbell MJ: Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. BMJ 317 (1998) 1202-1208
60. Kovatchev B, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke WL: Assessment of risk of severe hypoglycemia among adults with IDDM. Diabetes Care 21 (1998) 1870-1875
61. Koschinsky T, Heinemann L: Sensors for glucose monitoring: technical an clinical aspects. Diabetes/Metabolism Research and Reviews 17 (2001) 113-123
62. Guerci B, Floriot M, Bohme P, Durain D, Benichou M, Jellimann S, Drouin P: Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 26 (2003) 582-589
63. Maran A, Crepaldi G, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonerti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M: Continuous subcutaneous glucose monitoring in diabetic patients. A multicenter analysis. Diabetes Care 25 (2002) 347-352
64. Mastrototaro JJ: The MiniMed Continuous Glucose Monitoring System. Diabetes Technology & Therapeutics 2 (2000) S13-S18
65. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 25 (2002) 1499-1503
66. The Diabetes Research in Children Network (DirecNet) Study Group: Accuracy of the GlucoWatch G2 Biographer and the Continuous Glucose Monitoring System during hypoglycemia: experience of the Diabetes Research in Children Network. Diabetes Care 27 (1-3-2004) 722-726
67. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P: A pilot study of the Continuous Glucose Monitoring System: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 24 (2001) 2030-2034
68. Kubiak T, Hermanns N, Schreckling HJ, Kulzer B, Haak T: Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabetic Medicine 21 (2004) 487-490
69. Fahrenberg J, Leonhardt R, Hütmer P: Alltagsnahe Psychologie. Hogrefe, Göttingen (2003)
70. Cooper JW: Fatal asymptomatic hypoglycemia in elderly insulin-dependent diabetic patient taking an oral β-blocking medication. Diabetes Care 21 (1998) 2197-2198
71. Ter Braak EWMT, Appeman AMME, van de Laak MF, Stolk RP, van Haeften TV, Erkelens DW: Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 23 (2000) 1467-1471
72. Holleman F, Schmitt H, Rottiers R, Rees A, Symanowski S, Anderson JH, Group TB: Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin Lispro. Diabetes Care 1827-1832 (1997)
73. Ratner RE, Hirsch IB, Neifring JL, Garg SK, Mecca TE, Wilson CA, Study Group of Insulin Glargine in Type 1 Diabetes: Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 23 (2000) 639-643
74. Yki-Järvinen H, Dressler A, Ziemen M, the HOE 901/3002 Study Group: Less nocturnal hypoglycemia and better post-diner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy. Diabetes Care 23 (2000) 1130-1136
75. Kanc K, Janssen MM, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ, Heine RJ: Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycemia. Diabetologia 41 (1998) 322
76. Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care 19 (1996) 324
77. Renner R, Pf, Trautman M, Harzer O, Sauter K, Landgraf R: Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group. Diabetes Care 22 (1999) 784
78. Kaufman FR, Halvorson M, Miller D, Mackenzie M, Fisher LK, Pitukcheewanont P: Insulin pump therapy in type 1 pediatric patients: now and into the year 2000. Diabetes/Metabolism Research and Reviews 15 338
79. Pickup J, Mattock M, Kerry S: Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 324 (23-3-2002) 705
80. Cryer PE: Hypoglycemia begets hypoglycemia in IDDM. Diabetes 42 (1993) 1691-1693
81. Dagogo-Jack I, RC, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 9 (1994) 14264-14234
82. Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Porcellati F, Bottini P, Di Vincenzo A, Brunetti P, Bolli G: Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes 46 (1997) 1172-1181
83. Fanelli CG, Pampanelli S, Epifano Lea: Long-term recovery from unawareness, deficient counter-regulation and lack of cognitive dysfunctioning during hypoglycemia following institution of rational intensive therapy in IDDM. Diabetologia 37 (1994) 1265-1276
84. Cranston I, Lomas J, Maran A, Macdonald I., Amiel S: Restoration of hypoglycemia awareness in patients with long duration insulin dependent diabetes. The Lancet 344 (1994) 283-287
85. Fritsche A, Sturmvoll M, Häring HU, Gerich JE: Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. Journal of Clinical Endocrinology and Metabolism 85 (2000) 523
86. Ebert M, Hermanns N, Ellgring H, Kubiak T, Haak T: Einfluß von persönlichen diabetesspezifischen Einstellungen bei Typ-1-Diabetikern auf die Stoffwechselgüte. Diabetes und Stoffwechsel 11 (2002) 144
87. Gonder-Frederick L, Cox DJ, Clarke WL: Helping patients understand and recognize hypoglycemia. In: B. J. Anderson, R. R. Rubin (eds.): Practical psychology for diabetes clinicians. American Diabetes Association Inc, Alexandria, VA (1996) 83-92
88. Fehm-Wolfsdorf G, Kerner W, Peters A: Blutglukose Wahrnehmungstraining. Blood Glucose Awareness Training BGAT III. Lübeck, Eigenvertrieb (1998)
89. Cox DJ, Gonder-Frederick LA, Lee JH, Julian DM, Carter WR, Clarke WL: Effects and correlates of blood glucose awareness training among patients with IDDM. Diabetes Care 12 (1989) 13-18
90. Cox DJ, Carter WR, Gonder-Frederick LA, Clarke WL, Pohl S: Blood glucose discrimination training in IDDM patients. Biofeedback & Self-Regulation 13 (1988) 201-216
91. Cox DJ, Gonder-Frederick LA, Julian DM, Clarke WL: Long term follow up evaluation of blood glucose awareness training. Diabetes Care 17 (1994) 1-5
92. Cox DJ, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke WL: Blood glucose awareness training (BGAT-2). Diabetes Care 24 (2001) 637-642
93. Fehm-Wolfsdorf G, Kerner W, Peters A: Blutglukose Wahrnehmungstraining (BGAT). Manual für Patienten mit Typ 1 Diabetes. Lübeck (2001)
94. Gonder-Frederick L, Cox D, Kovatchev B, Julian D, Clarke W: The psychosocial impact of severe hypoglycemic episodes on spouses of patients with IDDM. Diabetes Care 20 (1-10-1997) 1543-1546
95. Fehm-Wolfsdorf G: Streg und Wahrnehmung. Huber, Bern (1994)
96. Cox DJ, Penberthy JK, Zrebiec J, Weinger K, Aikens JE, Frier B, Stetson B, DeGroot M, Trief P, Schaechinger H, Hermanns N, Gonder-Frederick L, Clarke W: Diabetes and driving mishaps: frequency and correlations from a multinational survey. Diabetes Care 26 (2003) 2329-2334
97. Kinsley BT, Weinger K, Bajaj M, Levy CJ, Simonson DC, Quigley M, Cox DJ, Jacobson AM: Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care 22 (1999) 1022-1028
98. Hepburn DA: Symptoms of hypoglycaemia. In: B. M. Frier, B. M. Fisher (eds.): Hypoglycaemia and diabetes. Clinical and physiological aspects. Edward Arnold, London, Boston, Melbourne Auckland (1993) 93-103
99. Matyka KCI, Evans M, Macdonald I, Lomas J, Amiel SA: Altered hierarchy of protective responses against severe hypoglycemia in normal aging healthy men. Diabetes Care 20 (1997) 135-141
100. Rubin RR, Peyrot M: Quality of life and diabetes. Diabetes/Metabolism Research and Reviews 15 (1999) 205-218
101. Strachan MW, Deary IJ, Ewing D, Frier BM: Recover of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 23 (2000) 305-312
102. Herpertz S, Petrak F, Albus C, Hirsch A, Kruse J, Kulzer B: Evidenzbasierte Diabetes-Leitlinie DDG. Psychosoziales und Diabetes mellitus. Diabetes und Stoffwechsel 12 (2003) 35-58